Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H10N4O2 |
Molecular Weight | 218.212 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=NC2=C1C(=O)N(CC#C)C(=O)N2C
InChI
InChIKey=IORPOFJLSIHJOG-UHFFFAOYSA-N
InChI=1S/C10H10N4O2/c1-4-5-14-9(15)7-8(11-6-12(7)2)13(3)10(14)16/h1,6H,5H2,2-3H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094257 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3193854 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27601997
in rats: 10 mg/kg/i.p
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
14114-46-6
Created by
admin on Fri Dec 15 18:32:14 GMT 2023 , Edited by admin on Fri Dec 15 18:32:14 GMT 2023
|
PRIMARY | |||
|
99562
Created by
admin on Fri Dec 15 18:32:14 GMT 2023 , Edited by admin on Fri Dec 15 18:32:14 GMT 2023
|
PRIMARY | |||
|
5YFR5SPS6T
Created by
admin on Fri Dec 15 18:32:14 GMT 2023 , Edited by admin on Fri Dec 15 18:32:14 GMT 2023
|
PRIMARY | |||
|
242985
Created by
admin on Fri Dec 15 18:32:14 GMT 2023 , Edited by admin on Fri Dec 15 18:32:14 GMT 2023
|
PRIMARY | |||
|
DMPX
Created by
admin on Fri Dec 15 18:32:14 GMT 2023 , Edited by admin on Fri Dec 15 18:32:14 GMT 2023
|
PRIMARY | |||
|
C057837
Created by
admin on Fri Dec 15 18:32:14 GMT 2023 , Edited by admin on Fri Dec 15 18:32:14 GMT 2023
|
PRIMARY | |||
|
DTXSID30161577
Created by
admin on Fri Dec 15 18:32:14 GMT 2023 , Edited by admin on Fri Dec 15 18:32:14 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD